Incidence, mortality, and survival analyses of patients with thymic lymphoma.

Wang, Li; Wang, Zhile; Huo, Lanqing; Zhao, Ailin

Wang, Li; Wang, Zhile; Huo, Lanqing; Zhao, Ailin.

Afiliação

Wang L; Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Wang Z; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Huo L; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China.
Zhao A; Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.

Front Oncol ; 12: 933672, 2022.

Article em En | MEDLINE | ID: mdl-36185268

Palavras-chave

chemotherapy; prognosis; radiotherapy; surgery; thymic lymphoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google